These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37824698)

  • 21. Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.
    Abgrall S; Matheron S; Le Moing V; Dupont C; Costagliola D;
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):151-8. PubMed ID: 11242182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection.
    Tellez I; Barragán M; Franco-Paredes C; Petraro P; Nelson K; Del Rio C
    Am J Med Sci; 2008 Mar; 335(3):192-7. PubMed ID: 18344692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: a retrospective study.
    Solomon FB; Angore BN; Koyra HC; Tufa EG; Berheto TM; Admasu M
    BMC Res Notes; 2018 Aug; 11(1):604. PubMed ID: 30126450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.
    Jarrin I; Geskus R; Bhaskaran K; Prins M; Perez-Hoyos S; Muga R; Hernández-Aguado I; Meyer L; Porter K; del Amo J;
    Am J Epidemiol; 2008 Sep; 168(5):532-40. PubMed ID: 18663213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
    Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
    Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
    Schäfer G; Hoffmann C; Arasteh K; Schürmann D; Stephan C; Jensen B; Stoll M; Bogner JR; Faetkenheuer G; Rockstroh J; Klinker H; Härter G; Stöhr A; Degen O; Freiwald E; Hüfner A; Jordan S; Schulze Zur Wiesch J; Addo M; Lohse AW; van Lunzen J; Schmiedel S;
    AIDS Res Ther; 2019 Nov; 16(1):34. PubMed ID: 31729999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study.
    Hung CC; Chen MY; Hsieh SM; Sheng WH; Chang SC
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):378-85. PubMed ID: 11015155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS.
    Yen YF; Chen M; Jen IA; Chuang PH; Lee CY; Lin SI; Chen YA
    Sci Rep; 2019 Mar; 9(1):3476. PubMed ID: 30837537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.
    Lee CY; Tseng YT; Lin WR; Chen YH; Tsai JJ; Wang WH; Lu PL; Tsai HC
    BMC Infect Dis; 2018 Jul; 18(1):352. PubMed ID: 30055564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnitude of opportunistic diseases and their predictors among adult people living with HIV enrolled in care: national level cross sectional study, Ethiopia.
    Weldegebreal T; Ahmed I; Muhiye A; Belete S; Bekele A; Kaba M
    BMC Public Health; 2018 Jul; 18(1):820. PubMed ID: 29970047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy.
    Dufour V; Cadranel J; Wislez M; Lavole A; Bergot E; Parrot A; Rufat P; Mayaud C
    Lung; 2004; 182(6):331-41. PubMed ID: 15765925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
    Tiruneh F; Deyas Y
    Sci Rep; 2020 Dec; 10(1):21468. PubMed ID: 33293656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.
    Radhi S; Alexander T; Ukwu M; Saleh S; Morris A
    BMC Infect Dis; 2008 Sep; 8():118. PubMed ID: 18796158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current epidemiology of Pneumocystis pneumonia.
    Morris A; Lundgren JD; Masur H; Walzer PD; Hanson DL; Frederick T; Huang L; Beard CB; Kaplan JE
    Emerg Infect Dis; 2004 Oct; 10(10):1713-20. PubMed ID: 15504255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.
    Okome-Nkoumou M; Guiyedi V; Ondounda M; Efire N; Clevenbergh P; Dibo M; Dzeing-Ella A
    Am J Trop Med Hyg; 2014 Feb; 90(2):211-5. PubMed ID: 24323514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.